Growth Metrics

Nu Skin Enterprises (NUS) Common Equity (2016 - 2026)

Nu Skin Enterprises' Common Equity history spans 17 years, with the latest figure at $805.2 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 23.61% to $805.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $805.2 million, a 23.61% increase, with the full-year FY2025 number at $805.2 million, up 23.61% from a year prior.
  • Common Equity hit $805.2 million in Q4 2025 for Nu Skin Enterprises, up from $799.8 million in the prior quarter.
  • Over the last five years, Common Equity for NUS hit a ceiling of $941.0 million in Q2 2022 and a floor of $651.5 million in Q4 2024.
  • Historically, Common Equity has averaged $834.3 million across 5 years, with a median of $832.1 million in 2022.
  • Biggest five-year swings in Common Equity: fell 23.36% in 2024 and later increased 23.61% in 2025.
  • Tracing NUS's Common Equity over 5 years: stood at $912.8 million in 2021, then decreased by 1.7% to $897.3 million in 2022, then decreased by 8.4% to $822.0 million in 2023, then dropped by 20.74% to $651.5 million in 2024, then increased by 23.61% to $805.2 million in 2025.
  • Business Quant data shows Common Equity for NUS at $805.2 million in Q4 2025, $799.8 million in Q3 2025, and $787.8 million in Q2 2025.